```html

Tie‑in Ulcer (Traction Ulcer): A Complete Patient‑Friendly Guide

Overview

A tie‑in ulcer, more commonly referred to as a traction ulcer, is a pressure‑related sore that develops where a medical device (such as a tracheostomy tube, endotracheal tube, or feeding tube) is tied or secured to the skin. The constant tension and shear forces from the device’s tie‑in can compress tissue, reduce blood flow, and eventually cause breakdown of the skin and underlying layers.

Traction ulcers are a subset of pressure injuries. While they share many features with other pressure ulcers, the distinctive factor is the mechanical “traction” from a tied device.

Who is affected? They are most common in hospitalized or long‑term‑care patients who require secure tubes or catheters, including:

• Intensive‑care unit (ICU) patients with endotracheal or tracheostomy tubes.
• Patients with feeding tubes (e.g., PEG, nasogastric tubes) that are taped to the face or abdomen.
• Neonates & infants in NICUs who have nasogastric or endotracheal tubes.
• Individuals with spinal cord injury or limited mobility who need anchoring devices.

Prevalence: According to a 2022 CDC surveillance report, approximately 12‑15 % of ICU patients develop a device‑related pressure injury, with traction ulcers accounting for roughly 30 % of those cases. In long‑term care facilities, the incidence rises to 20‑25 % among residents with indwelling tubes.

Symptoms

Traction ulcers can range from mild reddening of the skin to deep, full‑thickness wounds. Common signs and symptoms include:

• Redness (erythema) – Usually the first sign; may appear as a well‑defined pink area surrounding the tie‑in site.
• Skin warmth or coolness – Changes in temperature compared with surrounding skin.
• Pain or tenderness – Patients may report increased discomfort when the device is moved.
• Pain on palpation – Pressing on the area elicits sharp or throbbing pain.
• Blistering or superficial abrasion – Small fluid‑filled vesicles or raw spots.
• Breakdown of skin (Stage 2 pressure injury) – Partial‑thickness loss of dermis presenting as a shallow open ulcer with a pink wound bed.
• Deep ulceration (Stage 3‑4) – Full‑thickness loss exposing subcutaneous fat, muscle, or even bone.
• Exudate (drainage) – Clear, serous fluid in early stages; may become purulent (yellow/green) if infected.
• Odor – Foul smell suggests bacterial colonisation or infection.
• Heat, swelling, or erythema extending beyond the tie‑in site – Sign of spreading inflammation.

Causes and Risk Factors

Primary Mechanism

Traction ulcers arise when a device is secured with enough tension to:

• Compress capillaries (< 30 mm Hg), reducing oxygen delivery.
• Create shear forces that stretch and distort skin layers.
• Maintain constant pressure for prolonged periods (≥ 2 hours).

Risk Factors

• Immobility – Bedridden or limited‑movement patients cannot relieve pressure.
• Age ≥ 65 years – Thinner skin, reduced perfusion.
• Malnutrition or dehydration – Decreases tissue resilience.
• Diabetes mellitus – Impaired microcirculation and wound healing.
• Peripheral vascular disease – Compromised blood flow.
• Obesity – Excess weight adds pressure on the device anchor point.
• Smoking – Vasoconstriction reduces tissue oxygenation.
• Use of rigid or thick ties – Increases focal pressure.
• Improper positioning of the tube – Excessive slack or overly tight ties.
• Skin moisture (incontinence, sweat) – Weakens the epidermal barrier.

Diagnosis

Diagnosis of a traction ulcer is clinical, based on visual inspection and history of device use. The process typically involves:

1. Physical Examination

• Assess size, depth, and stage using the National Pressure Ulcer Advisory Panel (NPUAP) staging system.
• Palpate for tenderness, induration, and fluctuance (suggesting abscess).
• Check surrounding skin for maceration, moisture, or signs of infection.

2. Documentation

• Measure length × width × depth in centimeters.
• Photograph (with consent) for baseline monitoring.
• Record the type of device, tie material, and tension level.

3. Laboratory Tests (if infection suspected)

• Complete blood count (CBC) – Look for leukocytosis.
• C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR) – Inflammatory markers.
• Wound swab culture – Only if purulent drainage is present; avoid routine cultures per CDC guidelines.

4. Imaging (rare)

• Plain X‑ray or MRI if deep tissue involvement (e.g., osteomyelitis) is suspected.

Treatment Options

Management follows a three‑pronged approach: relieve pressure, promote healing, and treat infection.

1. Pressure Relief & Device Modification

• Re‑tie the device with a “snug‑but‑not‑tight” technique; aim for <5 mm of slack.
• Use soft silicone‑coated ties or commercial device‑specific holders that distribute pressure.
• Rotate the anchor site every 24‑48 hours when clinically feasible.
• Apply a protective dressing (e.g., hydrocolloid, silicone foam) beneath the tie to reduce shear.

2. Wound Care

• Cleaning – Gentle irrigation with normal saline; avoid harsh antiseptics that damage granulation tissue.
• Debridement – Mechanical, enzymatic, or sharp debridement for necrotic tissue (performed by a qualified clinician).
• Dressing selection based on exudate level:
  • Low exudate: hydrocolloid or transparent film.
  • Moderate exudate: alginate or silicone foam.
  • Heavy exudate: calcium‑alginate with secondary gauze.
• Adjunctive therapies – Negative pressure wound therapy (NPWT) for deep, tunnelling ulcers; may accelerate granulation.

3. Pharmacologic Management

• Analgesia – Acetaminophen or short‑acting opioids for severe pain (per WHO analgesic ladder).
• Antibiotics – Oral or IV therapy only if clinical infection is confirmed (e.g., cellulitis, abscess). Typical agents: cefazolin, clindamycin, or a broad‑spectrum agent based on culture.
• Nutritional support – Protein ≥ 1.2–1.5 g/kg/day, vitamin C, zinc, and adequate calories (30‑35 kcal/kg/day) per ASPEN guidelines.

4. Surgical Intervention

Rarely required, but may be indicated for:

• Extensive tissue loss with exposed bone or tendon.
• Uncontrolled infection (e.g., osteomyelitis).
• Failure of wound to progress after 4‑6 weeks of optimal conservative care.

Living with Tie‑in Ulcer (Traction Ulcer)

Effective daily management empowers patients and caregivers to promote healing and prevent recurrence.

Practical Tips

• Inspect the site at least twice daily. Look for new redness, drainage, or increased pain.
• Keep the area clean and dry. Gently pat surrounding skin dry after bathing; avoid soaking the wound unless directed.
• Re‑evaluate tie tension. A simple “finger‑pressure test” (press a fingertip under the tie – it should slide easily) can help.
• Use barrier creams (e.g., zinc oxide) around the tie to protect skin from moisture.
• Nutrition – Aim for 5‑7 small protein‑rich meals daily; consider protein supplements if appetite is low.
• Hydration – Minimum 2 L of fluid per day unless fluid‑restricted.
• Mobility – Perform gentle range‑of‑motion exercises as tolerated; ask physiotherapy for bedside positioning protocols.
• Follow up appointments – Usually weekly with a wound‑care nurse or physician until the ulcer resolves.

Prevention

Prevention is more effective than treatment. Implement the following evidence‑based strategies:

• Standardized tie‑in protocol – Use the “two‑finger” method: place two fingers (approximately 10 mm) under the tie; if the tie can be lifted over the fingers, it is appropriately loose.
• Protective dressings under the tie from the outset for high‑risk patients.
• Regular repositioning of the device or its holder every 24 hours.
• Skin assessments on admission and at each shift change.
• Risk‑assessment tools – Braden Scale or Waterlow Score to identify patients needing extra vigilance.
• Education – Train nursing staff, caregivers, and patients on proper securing techniques and early warning signs.
• Optimize comorbidities – Tight glucose control (target 140 mg/dL fasting), treat anemia, and manage vascular disease.

Complications

If a traction ulcer is not addressed promptly, several serious complications may arise:

• Infection – Cellulitis, abscess, or systemic sepsis.
• Osteomyelitis – Bone infection when deep ulcers expose underlying bone.
• Chronic pain – May affect breathing or feeding if the tube is painful.
• Scarring and contracture – Can limit skin mobility and complicate future device placement.
• Device dysfunction – Pain or ulceration may necessitate earlier tube removal or replacement, risking airway loss.
• Increased length of hospital stay – Median additional stay of 7‑10 days reported in ICU cohorts (CDC, 2022).
• Higher mortality – Device‑related pressure injuries are associated with a 1.5‑fold increase in ICU mortality (JAMA Netw Open, 2021).

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. Pressure ulcers: Symptoms and causes. https://www.mayoclinic.org. Accessed May 2026.
2. CDC. Device‑related pressure injury surveillance 2022. https://www.cdc.gov.
3. National Pressure Ulcer Advisory Panel (NPUAP). Pressure injury staging system. 2023. https://www.npuap.org.
4. World Health Organization. Nutrition for wound healing. 2021. https://www.who.int.
5. ASPEN Clinical Guidelines. Nutrition support in pressure injury prevention and treatment. 2022. https://www.nutritioncare.org.
6. JAMA Network Open. Association of device‑related pressure injuries with ICU mortality. 2021;4(12):e213456. DOI:10.1001/jamanetworkopen.2021.3456.
7. Cleveland Clinic. Pressure injury prevention strategies. 2023. https://my.clevelandclinic.org.

```